Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    2372896 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hypercholesterolemia
Intervention:
2 Completed Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes
Conditions: Diabetes Mellitus Type 2;   Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: simvastatin;   Drug: Ezetimibe 10/Simvastatin 20

Indicates status has not been verified in more than two years